I for one conclude that if RD goes as it should, and (I think) proves concept, we have a very bright future. Roger is not a dynamic public speaker but I have heard worse, I think he comes across pragmatically, which is probably better than having a Sam Waksal figure--He talked about the water soluable pro-drug I would guess is going to be an intra venous formulation. He also hit on the massive punch of the non-numbered high impact, he called it CX-1921 when I spoke to him. The drug worked on a few micrograms and completely offset high dose fentanyl RD IN SHORT ORDER, it almost looked like the POST-DRUG recovery respiration was hyperventilation.It will be interesting to hear Neuro's thoughts, there was nary a peep about SGP....HMMM..I thought the pre-clinical CX-1739 ADHD data was very compelling...
Market Data 
Markets 
AI
